Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pascal Sève

Showing results (171-180 of 198) with videos related to

Pageof 20
Sort By:
Expert Opinion on Biological Therapy|March 20, 2019
Expert opinion on the use of biological therapy in non-infectious uveitisSara Touhami, Eléonore Diwo, Pascal Sève, et al.
Vaccine|May 21, 2026
Immunological efficacy and safety of influenza vaccination in adults with sarcoidosis: the SARCOVAC studyBrigitte Ranque, Florence Galtier, Hilario Nunes, et al.
Medicine|July 22, 2016
Digestive-tract sarcoidosis: French nationwide case-control study of 25 casesEtienne Ghrenassia, Arsene Mekinian, Catherine Chapelon-Albric, et al.
Journal of Clinical Medicine|November 26, 2022
The Spectrum of Still's Disease: A Comparative Analysis of Phenotypic Forms in a Cohort of 238 PatientsPierre-Antoine Neau, Thomas El-Jammal, Clément Javaux, et al.
Medicine|July 17, 2015
Sarcoidosis Occurring After Solid Cancer: A Nonfortuitous Association: Report of 12 Cases and Review of the LiteratureAurélie Grados, Mikael Ebbo, Emmanuelle Bernit, et al.
Ophthalmology|June 8, 2025
Corticosteroids with or without Conventional Disease-Modifying Antirheumatic Drug as First-Line Therapy in Nonanterior Sarcoidosis UveitisRobin Jacquot, Pascal Sève, Guillaume Mulier, et al.
American Journal of Ophthalmology|February 16, 2022
Lower Relapses Rate With Infliximab Versus Adalimumab in Sight-Threatening Uveitis: A Multicenter Study of 330 PatientsGeorgina Maalouf, Anaïs Andrillon, Mathilde Leclercq, et al.
Rheumatology (Oxford, England)|December 17, 2021
Immune thrombocytopenia with clinical significance in systemic lupus erythematosus: a retrospective cohort study of 90 patientsMickaël Roussotte, Mathieu Gerfaud-Valentin, Arnaud Hot, et al.
Ophthalmology|May 21, 2025
Comparative effectiveness of intravenous versus subcutaneous tocilizumab for refractory uveitis: a retrospective analysisMathilde Leclercq, Robin Jacquot, Camille Charbonnier, et al.
Rheumatology (Oxford, England)|October 18, 2017
Familial Mediterranean fever mutations are hypermorphic mutations that specifically decrease the activation threshold of the Pyrin inflammasomeYvan Jamilloux, Lucie Lefeuvre, Flora Magnotti, et al.
Pageof 20

Showing results (171-180 of 198) with videos related to

Sort By:
Pageof 20
Expert Opinion on Biological Therapy|March 20, 2019
Expert opinion on the use of biological therapy in non-infectious uveitisSara Touhami, Eléonore Diwo, Pascal Sève, et al.
Vaccine|May 21, 2026
Immunological efficacy and safety of influenza vaccination in adults with sarcoidosis: the SARCOVAC studyBrigitte Ranque, Florence Galtier, Hilario Nunes, et al.
Medicine|July 22, 2016
Digestive-tract sarcoidosis: French nationwide case-control study of 25 casesEtienne Ghrenassia, Arsene Mekinian, Catherine Chapelon-Albric, et al.
Journal of Clinical Medicine|November 26, 2022
The Spectrum of Still's Disease: A Comparative Analysis of Phenotypic Forms in a Cohort of 238 PatientsPierre-Antoine Neau, Thomas El-Jammal, Clément Javaux, et al.
Medicine|July 17, 2015
Sarcoidosis Occurring After Solid Cancer: A Nonfortuitous Association: Report of 12 Cases and Review of the LiteratureAurélie Grados, Mikael Ebbo, Emmanuelle Bernit, et al.
Ophthalmology|June 8, 2025
Corticosteroids with or without Conventional Disease-Modifying Antirheumatic Drug as First-Line Therapy in Nonanterior Sarcoidosis UveitisRobin Jacquot, Pascal Sève, Guillaume Mulier, et al.
American Journal of Ophthalmology|February 16, 2022
Lower Relapses Rate With Infliximab Versus Adalimumab in Sight-Threatening Uveitis: A Multicenter Study of 330 PatientsGeorgina Maalouf, Anaïs Andrillon, Mathilde Leclercq, et al.
Rheumatology (Oxford, England)|December 17, 2021
Immune thrombocytopenia with clinical significance in systemic lupus erythematosus: a retrospective cohort study of 90 patientsMickaël Roussotte, Mathieu Gerfaud-Valentin, Arnaud Hot, et al.
Ophthalmology|May 21, 2025
Comparative effectiveness of intravenous versus subcutaneous tocilizumab for refractory uveitis: a retrospective analysisMathilde Leclercq, Robin Jacquot, Camille Charbonnier, et al.
Rheumatology (Oxford, England)|October 18, 2017
Familial Mediterranean fever mutations are hypermorphic mutations that specifically decrease the activation threshold of the Pyrin inflammasomeYvan Jamilloux, Lucie Lefeuvre, Flora Magnotti, et al.
Pageof 20